The objective of the workshop that is the subject of this summary report was to present the challenges and opportunities for medical devices as perceived by the key stakeholders in the field. The agenda, and hence the summaries of the presentations that were made in the workshop and which are presented in this summary report, was organized to first examine the nature of innovation in the field and the social and economic infrastructure that supports such innovation. The next objective was to identify and discuss the greatest unmet clinical needs, with a futuristic view of technologies that might meet those needs. And finally, consideration was given to the barriers to the application of new technologies to meet clinical needs.
Kathi E. Hanna, Frederick J. Manning, Peter Bouxsein, and Andrew Pope, Editors, Based on a Workshop of the Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Board on Health Sciences Policy
1 Front Matter; 2 1 Introductory Overview; 3 2 Keynote Session; 4 3 The Nature of Medical Innovation; 5 4 Sources and Support of Medical Devices Innovation; 6 5 The Challenges Ahead; 7 6 Summary and Conclusions; 8 Appendix A: Workshop Agenda; 9 Appendix B: Speakers' Biographical Sketches; 10 Appendix C: Registered Participants
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Sciences Policy, Committee on Ethical Considerations for Revisions to DHHS Regulations for Protection of Prisoners Involved in Research, Andrew Pope, Cori Vanchieri, Lawrence O. Gostin
Institute of Medicine, Division of Health Sciences Policy, and Medical Devices Roundtable on Research and Development of Drugs, Biologics, Jonathan R. Davis, Sarah Pitluck, Peter Bouxsein, Ronald W. Estabrook, M.D. Yaffe, Sumner
Institute of Medicine, Board on Health Sciences Policy, Medical Follow-Up Agency, Committee on Alternative Funding Strategies for DOD's Peer Reviewed Medical Research Programs, Kathi E. Hanna, Michael McGeary
National Research Council, Policy and Global Affairs, and Law Committee on Science, Technology, Committee on Daubert Standards, Anne-Marie Mazza, Kathi E. Hanna
Institute of Medicine, Board on Health Sciences Policy, Committee on the Longitudinal Study of Astronaut Health, Jr. Worth, Melvin H., Frederick J. Manning, David E. Longnecker
Institute of Medicine, Board on Health Sciences Policy, Committee for Assessment of NIH Centers of Excellence Programs, Ronald Estabrook, Michael McGeary, Frederick J. Manning
Institute of Medicine, Board on Health Sciences Policy, Committee on Evaluation of the Metropolitan Medical Response Program, Lewis Goldfrank, Frederick J. Manning
Institute of Medicine, Board on Health Sciences Policy, Committee on Evaluation of the Metropolitan Medical Response System Program, Lewis Goldfrank, Frederick J. Manning
Institute of Medicine, and Medical Devices Roundtable on Research and Development of Drugs, Biologics, Ronald W. Estabrook, Janet Woodcock, Vivian P. Nolan, Jonathan R. Davis